| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |